Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Camp4 Therapeutics (CAMP) FCF Margin: 2023-2025

Historic FCF Margin for Camp4 Therapeutics (CAMP) over the last 1 years, with Sep 2025 value amounting to -1,410.94%.

  • Camp4 Therapeutics' FCF Margin fell 1704481.00% to -1,410.94% in Q3 2025 from the same period last year, while for Sep 2025 it was -1,254.97%, marking a year-over-year change of. This contributed to the annual value of -7,061.50% for FY2024, which is 574793.00% up from last year.
  • As of Q3 2025, Camp4 Therapeutics' FCF Margin stood at -1,410.94%, which was down 104.49% from -689.98% recorded in Q2 2025.
  • In the past 5 years, Camp4 Therapeutics' FCF Margin registered a high of 15,633.87% during Q3 2024, and its lowest value of -1,777.45% during Q4 2024.
  • Over the past 3 years, Camp4 Therapeutics' median FCF Margin value was -1,050.46% (recorded in 2025), while the average stood at 4,090.91%.
  • Data for Camp4 Therapeutics' FCF Margin shows a maximum YoY slumped of 1,704,481bps (in 2025) over the last 5 years.
  • Quarterly analysis of 3 years shows Camp4 Therapeutics' FCF Margin stood at 14,489.16% in 2023, then plummeted by 1,626,661bps to -1,777.45% in 2024, then plummeted by 1,704,481bps to -1,410.94% in 2025.
  • Its last three reported values are -1,410.94% in Q3 2025, -689.98% for Q2 2025, and -1,699.18% during Q1 2025.